Rising costs of key chemicals choke production at drug ingredient makers

India's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disruptions linked to the West Asia conflict. This has led to production halts for several units, with paracetamol API prices more than doubling, impacting the entire pharmaceutical value chain.